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CASE REPORT

Dual-chamber pacing using a hybrid transvenous and leadless
pacing approach
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Abstract
An elderly gentleman with a dual-chamber pacemaker presented to our institution
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with symptoms of symptomatic bradycardia and high-grade atrioventricular (AV)
block. Device interrogation revealed failure to capture in the right ventricle (RV) lead
with bipolar pacing, high RV pacing threshold with unipolar pacing, and high impedance
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suggesting lead fracture. The atrial lead function was normal. Given his advanced age,
gait instability, and dementia, the decision was made to proceed with Micra AV pacemaker implantation, while programming his dual-chamber pacemaker to AAIR mode,
thus maintaining AV synchrony by tracking paced atrial impulses and providing ventricular pacing.
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INTRODUCTION

tion with a dual-chamber DDDR pacemaker (Boston Scientific L101
pacemaker with Medtronic 5076 leads; implanted in 2015) presented

The use of permanent pacemakers is a class I indication for the treatment of various

bradyarrhythmias.1

to our institution with symptomatic bradycardia with high-grade AV

Pacemakers have evolved from

block (Figure 1). Device interrogation revealed failure to capture in the

subcutaneous devices with surgically implanted epicardial leads to

RV lead with bipolar pacing, high RV pacing threshold with unipolar

transvenously placed endocardial leads and more recently to leadless

pacing (3.5 V at 1 milliseconds), and high impedance (>3000 ohms) sug-

devices using Micra pacemakers (Medtronic; Minneapolis, MN, USA).

gesting lead fracture. Atrial lead function was normal with no change

We present a unique case where a patient with a prior DDDR dual-

since implantation; however, the atrial pacing threshold was 1.5 V at

chamber pacemaker presented with a malfunctioning right ventricle

0.4 milliseconds with bipolar pacing and 0.5 V at 0.4 milliseconds with

(RV) lead. The patient has significant sinus-node dysfunction and high

unipolar pacing.

grade atrioventricular (AV) block. We implanted a Micra AV leadless

Given the unreliability of continuous unipolar ventricular pacing in

pacemaker to maintain AV synchrony by tracking paced atrial activity

this pacemaker-dependent patient, his high fall risk given his gait

and providing ventricular pacing.

instability, elderly age, and prior RV lead failure, we felt that procedure and post procedure related complications of adding new RV
lead will be significantly higher in our patient. Given these multiple
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CASE HISTORY

factors, we felt that the best approach was to proceed with Micra
AV pacemaker implantation while reprogramming his dual-chamber

A 92-year-old male with a past medical history significant for dementia,

pacemaker to AAIR mode. The procedure was successful without

chronic kidney disease, high-grade AV block, and sinus node dysfunc-

any complications. Micra device interrogation findings at the time of

Abbreviations: RV, right ventricle; AV, atrioventricular
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FIGURE 1

Telemetry monitoring strip on presentation to the hospital [Color figure can be viewed at wileyonlinelibrary.com]

implantation were: impedance of 690 ohms, sensing: 12.2 mV, and pac-

femoral venous catheter. Both devices provide RV pacing only; how-

ing threshold: 0.5 V at 0.24 milliseconds. The patient’s dual-chamber

ever, the Micra AV can maintain reasonable AV synchrony using an

pacemaker was programmed at AAIR 55/105 bpm with the leadless

accelerometer-based atrial sensing algorithm to track the patient’s

pacemaker programmed at VDD 45/105 bpm. The lower limit of the

sinus rhythm.6

atrial rate was programmed faster than the RV lower rate to pre-

The implantation of a permanent pacemaker improves the patient’s

vent pacemaker syndrome at rest or after premature ventricular con-

quality of life when they have various electrical conduction diseases.

tractions. Both device interrogations at 3-month follow-up revealed

However, the quality-of-life benefits associated with dual-chamber

stable device numbers, 89% RA pacing, 99% RV pacing, with appro-

pacing as compared with continuous ventricular pacing are most

priate paced atrial rhythm tracking from the Mica device at 95%

notable in those patients who have sinus node dysfunction.7 Advanced

(Figure 2A,B,C).

age is an independent risk factor for the development of most arrhythmias due to significant structural and electrical remodeling. Elderly
patients will frequently require a dual-chamber pacing due to coex-
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DISCUSSION

isting sinus node dysfunction, AV block, and His-Purkinje system
disease.8

Pacemakers with transvenous leads are by far the most common

In the case described above, the mechanism of RV lead malfunc-

approach when permanent therapy for bradycardia is needed. How-

tion could be due to subclavian crush syndrome due to lead com-

ever, procedure-related complications, early and late leads malfunc-

pression and entrapment between the first rib and clavicle. The

tion, and venous access limitations are common, with higher complica-

management strategy for a malfunctioning RV lead is either new RV

tion rates in elderly patients.2,3

lead placement, if the subclavian vein is patent, and if not, then RV

Patients with dementia might not be able to follow some activity

lead extraction and re-implantation of a new RV lead or implantation

restrictions after transvenous pacemaker. Prior study suggested that

of a contralateral device and new transvenous leads with the abandon-

patients with cognitive impairment or dementia have similar post pace-

ment of prior leads. Given the patient advanced age, comorbidities, our

maker implant complication rates when compared to patients without

concerns as well as his family concerns of having another early lead

cognitive impairment or dementia.4

However another study suggested

failure, and the unreliability of continuous unipolar right ventricular

that elderly patients (>75 years old) with dementia have higher rates

pacing, the less traumatic approach in our opinion was to proceed with

of complications after tranvenous pacemaker lead placement.5

Micra AV pacemaker implantation, while reprograming his old dual-

MICRA and MICRA AV are the only two approved leadless pacemakers in United States. These devices are placed in the RV via a

chamber device to AAIR mode thus providing synchronous AV pacing
with a hybrid approach.

NONA ET AL .

F I G U R E 2 (A) ECG from patient demonstrating unipolar atrial pacing from a dual-chamber pacemaker (AAIR mode) and ventricular pacing
from a Micra AV leadless pacemaker. (B) Chest X-ray demonstrating a dual-chamber pacemaker with leads in the right atrium and right ventricle
and Micra AV pacemaker in the right ventricle. (C) AV synchrony achieved with atrial and ventricular pacing using accelerometer-based atrial
sensing algorithm of the Micra AV [Color figure can be viewed at wileyonlinelibrary.com]
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CONCLUSION

The Micra AV device can appropriately sense and track paced atrial
activity. A hybrid pacing approach of prior implanted atrial lead and
Micra AV is feasible in patients who require dual-chamber pacing. Such
an approach should be considered in patients with a dual-chamber
pacemaker who require RV pacing and have a malfunctioning RV lead
and in patients with a single-chamber atrial pacemaker who later
require ventricular pacing and have limited subclavian venous access
or are at risk for lead dislodgment.
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